ArticleCancers2021

Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study.

In Gyu Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.